South Korea · Delayed Price · Currency is KRW LAMEDITECH Statistics
Total Valuation
LAMEDITECH has a market cap or net worth of KRW 23.46 billion. The enterprise value is 27.27 billion.
| Market Cap | 23.46B |
| Enterprise Value | 27.27B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
LAMEDITECH has 8.80 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 8.80M |
| Shares Outstanding | 8.80M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 30.32% |
| Owned by Institutions (%) | n/a |
| Float | 4.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.22 |
| PB Ratio | 4.78 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.54.
| Current Ratio | 1.00 |
| Quick Ratio | 0.43 |
| Debt / Equity | 1.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.61 |
| Interest Coverage | -18.19 |
Financial Efficiency
Return on equity (ROE) is -102.23% and return on invested capital (ROIC) is -44.42%.
| Return on Equity (ROE) | -102.23% |
| Return on Assets (ROA) | -33.22% |
| Return on Invested Capital (ROIC) | -44.42% |
| Return on Capital Employed (ROCE) | -127.40% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.30% in the last 52 weeks. The beta is 0.32, so LAMEDITECH's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -64.30% |
| 50-Day Moving Average | 2,788.60 |
| 200-Day Moving Average | 4,681.48 |
| Relative Strength Index (RSI) | 40.03 |
| Average Volume (20 Days) | 26,065 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAMEDITECH had revenue of KRW 5.56 billion and -9.75 billion in losses. Loss per share was -1,108.95.
| Revenue | 5.56B |
| Gross Profit | 2.22B |
| Operating Income | -10.81B |
| Pretax Income | -9.75B |
| Net Income | -9.75B |
| EBITDA | -10.20B |
| EBIT | -10.81B |
| Loss Per Share | -1,108.95 |
Balance Sheet
The company has 3.75 billion in cash and 7.57 billion in debt, with a net cash position of -3.81 billion or -433.09 per share.
| Cash & Cash Equivalents | 3.75B |
| Total Debt | 7.57B |
| Net Cash | -3.81B |
| Net Cash Per Share | -433.09 |
| Equity (Book Value) | 4.90B |
| Book Value Per Share | 556.15 |
| Working Capital | 41.19M |
Cash Flow
In the last 12 months, operating cash flow was -10.56 billion and capital expenditures -1.76 billion, giving a free cash flow of -12.31 billion.
| Operating Cash Flow | -10.56B |
| Capital Expenditures | -1.76B |
| Depreciation & Amortization | 609.92M |
| Net Borrowing | 9.26B |
| Free Cash Flow | -12.31B |
| FCF Per Share | -1,398.95 |
Margins
Gross margin is 39.95%, with operating and profit margins of -194.36% and -175.40%.
| Gross Margin | 39.95% |
| Operating Margin | -194.36% |
| Pretax Margin | -175.40% |
| Profit Margin | -175.40% |
| EBITDA Margin | -183.39% |
| EBIT Margin | -194.36% |
| FCF Margin | n/a |
Dividends & Yields
LAMEDITECH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -41.58% |
| FCF Yield | -52.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAMEDITECH has an Altman Z-Score of -2.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.98 |
| Piotroski F-Score | 2 |